Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

FOLR2 antibody

This Mouse Monoclonal antibody specifically detects FOLR2 in WB. It exhibits reactivity toward Human.
Catalog No. ABIN6243737

Quick Overview for FOLR2 antibody (ABIN6243737)

Target

See all FOLR2 Antibodies
FOLR2 (Folate Receptor 2 (Fetal) (FOLR2))

Reactivity

  • 43
  • 13
  • 5
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Human

Host

  • 38
  • 8
  • 1
  • 1
Mouse

Clonality

  • 36
  • 9
  • 2
Monoclonal

Conjugate

  • 28
  • 6
  • 4
  • 4
  • 3
  • 2
This FOLR2 antibody is un-conjugated

Application

  • 39
  • 26
  • 16
  • 13
  • 6
  • 4
  • 3
  • 3
  • 2
  • 1
  • 1
Western Blotting (WB)

Clone

1905CT501-41-76
  • Purification

    This antibody is purified through a protein G column, followed by dialysis against PBS.

    Immunogen

    This FOLR2 antibody is generated from a mouse immunized with a recombiant protein from human FOLR2.

    Isotype

    IgG2b kappa
  • Application Notes

    WB: 1:1000-1:2000

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Purified monoclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C,-20 °C

    Expiry Date

    6 months
  • Target

    FOLR2 (Folate Receptor 2 (Fetal) (FOLR2))

    Alternative Name

    FOLR2

    Background

    Binds to folate and reduced folic acid derivatives and mediates delivery of 5-methyltetrahydrofolate and folate analogs into the interior of cells. Has high affinity for folate and folic acid analogs at neutral pH . Exposure to slightly acidic pH after receptor endocytosis triggers a conformation change that strongly reduces its affinity for folates and mediates their release.

    Molecular Weight

    29280

    UniProt

    P14207

    Pathways

    Dicarboxylic Acid Transport
You are here:
Chat with us!